Literature DB >> 22632394

Topical therapies for oral lichen planus management and their efficacy: a narrative review.

José Bagan1, Domenico Compilato, Carlo Paderni, Giuseppina Campisi, Vera Panzarella, Maria Picciotti, Guido Lorenzini, Olga Di Fede.   

Abstract

Oral Lichen Planus (OLP) is a chronic inflammatory condition implicating T cell-mediated cytotoxicity, and involving oral mucosal surfaces. Several therapeutic regimens have been evaluated to treat OLP and pain related, but often without high level of evidence. Topical formulations are the favourite for the majority of cases; bioadhesive formulations have been considered very useful and practical for local drug delivery in oral mucosa, due to the increased residence time on the oral mucosa of the dosage forms and better therapeutic efficacy. In this narrative review, authors try to illustrate the current topical managements for OLP from the accessible literature on this topic. Steroids are very helpful in discomfort and making better quality of life: they are considered the first-line treatment even if they could cause secondary candidosis, and sometimes bad taste, nausea, dry mouth, sore throat or swollen mouth. Other substances or devices by topical administration are adopted especially when the first line approach is refractory. This is the case when retinol with its synthetic and natural analogues (retinoids), hyaluronic acid, or Aloe Vera are chosen. Recent topical applications for OLP therapy include phototherapy and low/high energy pulsing light; the treatment with extracorporeal photochemotherapy is also reasonable and promising. Finally, calcineurin inhibitors (i.e. cyclosporine, tacrolimus and pimecrolimus), antioxidant and biologics (i.e alefacept, efalizumab, basiliximab, TNF-α inhibitors - infliximab, rituximab) may be alternative approaches when OLP does not respond to the standard protocols. In this scenario, there are several studies on molecules different from glucocorticosteroids, but not sufficient or statistically adequate to justify their evidence-based use in OLP; large randomized placebo controlled trials are required to evaluate the safety and effectiveness of these non conventional therapies. In conclusion, since OLP is a chronic disease and requires long-term management, the dental/medical practitioner, who treats OLP patients, needs to know the natural history of OLP, how to monitor, and how to treat, taking in account all of the available modalities conventional and not, with pros and cons.

Entities:  

Mesh:

Year:  2012        PMID: 22632394     DOI: 10.2174/138161212803307617

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Gustatory function and taste perception in patients with oral lichen planus and tongue involvement.

Authors:  Valerie G A Suter; Simona Negoias; Hergen Friedrich; Basile N Landis; Marco-Domenico Caversaccio; Michael M Bornstein
Journal:  Clin Oral Investig       Date:  2016-06-06       Impact factor: 3.573

Review 2.  Efficacy of topical non-steroidal immunomodulators in the treatment of oral lichen planus: a systematic review and meta-analysis.

Authors:  Eduardo Liberato da Silva; Taiane Berguemaier de Lima; Pantelis Varvaki Rados; Fernanda Visioli
Journal:  Clin Oral Investig       Date:  2021-08-03       Impact factor: 3.573

3.  Efficacy of platelet-rich fibrin compared with triamcinolone acetonide as injective therapy in the treatment of symptomatic oral lichen planus: a pilot study.

Authors:  Francesco Bennardo; Francesco Liborio; Selene Barone; Alessandro Antonelli; Caterina Buffone; Leonzio Fortunato; Amerigo Giudice
Journal:  Clin Oral Investig       Date:  2021-01-07       Impact factor: 3.573

4.  Hyaluronan-phosphatidylethanolamine polymers form pericellular coats on keratinocytes and promote basal keratinocyte proliferation.

Authors:  Caitlin J Symonette; Aman Kaur Mann; Xiao Cherie Tan; Cornelia Tolg; Jenny Ma; Francisco Perera; Arjang Yazdani; Eva A Turley
Journal:  Biomed Res Int       Date:  2014-09-09       Impact factor: 3.411

5.  Screening of FDA-Approved Drugs for Inhibitors of Japanese Encephalitis Virus Infection.

Authors:  Shaobo Wang; Yang Liu; Jiao Guo; Peilin Wang; Leike Zhang; Gengfu Xiao; Wei Wang
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

Review 6.  Therapeutic effectiveness of alternative medications in oral lichen planus: A systematic review.

Authors:  Jayanth Kumar Vadivel; Devaraj Ezhilarasan; Meera Govindarajan; Elangovan Somasundaram
Journal:  J Oral Maxillofac Pathol       Date:  2020-09-09

7.  A randomized clinical trial of topical dexamethasone vs. cyclosporine treatment for oral lichen planus.

Authors:  M Georgaki; E Piperi; V-I Theofilou; E Pettas; E Stoufi; N-G Nikitakis
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2022-03-01

Review 8.  Advances in the Application of Electrospun Drug-Loaded Nanofibers in the Treatment of Oral Ulcers.

Authors:  Yangqi Zhou; Menglong Wang; Chao Yan; Hui Liu; Deng-Guang Yu
Journal:  Biomolecules       Date:  2022-09-07

9.  Clinical Evaluation of Efficacy of Triamcinolone Acetonide with Tacrolimus in the Management of Oral Lichen Planus: A Pilot Prospective Observational Study.

Authors:  Cheshta Walia; Neelakshi Singh Rallan; Anu Premkumar; Sudip Roy
Journal:  Contemp Clin Dent       Date:  2022-09-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.